Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

BIOLASE, Inc. (BIOL) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

BIOLASE is a medical technology company that develops, manufactures and markets dental lasers; distributes and markets dental imaging equipment; and manufactures products that are focused on technologies that advance the practice of dentistry and medicine. BIOL’s laser products incorporate approximately … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Endocyte, Inc. (NASDAQ: ECYT) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Endocyte is focused on developing targeted therapies that treat cancer and inflammatory diseases. Using proprietary technology, Endocyte creates novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company aims to improve the specificity, safety and efficacy of highly … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Cytokinetics, Inc. (CYTK) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. The company’s lead drug candidate is in phase II … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Navidea Biopharmaceuticals, Inc. (NAVB) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative precision diagnostic agents and radiopharmaceutical agents. NAVB is actively developing four radiopharmaceutical agent platforms: Lymphoseek®, 4694, CFT and RIGScan™. The company’s strategy is to bring to … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

ThermoGenesis Corp. (KOOL) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

ThermoGenesis develops and manufactures automated blood processing systems and disposable products: the BioArchive(R) System, used for cryopreserving and archiving cord blood stem cell units for transplant; the AXP(R) AutoXpress(R) Platform (AXP), a proprietary family of automated devices that includes the … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Trinity Biotech plc (TRIB) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems for the point-of-care and clinical laboratory segments of the diagnostic market. The company’s products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Attunity Ltd. (ATTU) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Attunity is a software vendor that enables ‘real-time enterprise.’ In September 2011, the company acquired and merged with RepliWeb, a provider of Enterprise File Replication, Managed File Transfer (MFT), and Application Release Automation, for enterprise data centers and cloud environments. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Novelos Therapeutics, Inc. (NVLT) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Novelos Therapeutics is a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer. The company’s portfolio includes: I-124-CLR1404, currently in phase 1-2 clinical trials; I-131-CLR1404, in phase 1b dose-escalation trial; CLR1502, a small-molecule optical imaging agent for … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Superconductor Technologies, Inc. (SCON) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Superconductor Technologies engages in the development and production of high temperature superconducting (HTS) materials and associated technologies. SCON offers commercialized wireless products using its proprietary technology in superconducting power applications, RF filters, and cryocoolers, as well as in wireless networks. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Pharmacyclics, Inc. (PCYC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Pharmacyclics is a clinical-stage biopharmaceutical company focusing on discovering, developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The company currently has three candidates in clinical development and several molecules in preclinical development, and has … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment